← 홈

CGT

1,235개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,235개
CGTBiologicStephan Grupp MD PhDPhase 2

huCART19 (Autologous, humanized anti-CD19 CAR T cell therapy, Autologous, humanized anti-CD19 CAR T cell therapy (huCART19))

B-cell Acute Lymphoblastic Leukemia; B Lineage Lymphoblastic Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 13상태 RECRUITING
CGTAAVBiologicstaleByron LamPhase 2

10e11 vg (Injection of AAV2-REP1, Injection of AAV2-REP1 (10e11 vg))

Choroideremia · Choroideremia

#Choroideremia#CGT#Phase2#세포유전치료#CAR-T+2
효능 ORR 82.3%임상시험 13상태 ACTIVE
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

T cell infusion agent targeting BCMA chimeric antigen receptor (T cell infusion agent targeting BCMA chimeric antigen receptor)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+3
효능 ORR 42.9%임상시험 13상태 ACTIVE
CGTBiologicstaleiCell Gene TherapeuticsPhase 1

Anti-CD33 CAR T-cells (Anti-CD33 CAR T-cells)

Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 12상태 RECRUITING
CGTBiologicstaleBiohaven Pharmaceuticals, Inc.Phase 1

CIML-NK cell therapy (CIML-NK cell therapy)

Acute Myeloid Leukemia Refractory; Acute Myeloid Leukemia, in Relapse · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 12상태 RECRUITING
CGTBiologicstaleShenzhen Institute for Innovati…Phase 2

Drugs and anti-CD19 CAR transduced T cells (Drugs and anti-CD19 CAR transduced T cells)

Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 12상태 ACTIVE
CGTBiologicstaleVyriad, Inc.Phase 2

Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter (Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter)

Fallopian Tube Clear Cell Adenocarcinoma; Fallopian Tube Endometrioid Adenocarcinoma · Fallopian Tube Clear Cell Adenocarcinoma

#FallopianTubeClearCellAdenocarci#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 0%임상시험 12상태 ACTIVE
CGTBiologicstaleHrain Biotechnology Co., Ltd.Phase 1

anti-MESO CAR-T cells (anti-MESO CAR-T cells)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 12상태 ACTIVE
CGTBiologicTaiho Oncology, Inc.Phase 2

ASTX660 (ASTX660)

Solid Tumors; Lymphoma · Solid Tumors

#SolidTumors#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 11상태 RECRUITING
CGTBiologicKyverna TherapeuticsPhase 2

KYV-101 anti-CD19 CAR-T cell therapy (KYV-101 anti-CD19 CAR-T cell therapy)

Lupus Nephritis; Lupus Nephritis - World Health Organization (WHO) Class III · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 11상태 RECRUITING
CGTBiologicstaleCARsgen Therapeutics Co., Ltd.Phase 1

anti-GPC3 CAR-T (anti-GPC3 CAR-T)

Hepatocellular Carcinoma · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 11상태 ACTIVE
CGTBiologicNational Heart, Lung, and Blood…vedotinPhase 1

AVL (AAV8hAAT, AAV8hAAT(AVL))

Alpha 1-Antitrypsin Deficiency · Alpha 1-Antitrypsin Deficiency

#Alpha1-AntitrypsinDeficiency#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 10상태 RECRUITING
CGTBiologicstaleAsclepius Technology Company Gr…Phase 1

Anti-BCMA CAR-NK Cells (Anti-BCMA CAR-NK Cells)

Multiple Myeloma, Refractory · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 10상태 ACTIVE
CGTBiologicTakedaPhase 2

Anti-CD19 CAR T Cells Preparation (Anti-CD19 CAR T Cells Preparation)

Hematologic Malignancies · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 20%임상시험 10상태 RECRUITING
CGTBiologicstaleShenzhen Celconta Life Science …Phase 1

Claudin18.2-targeted CAR-T Cells (Claudin18.2-targeted CAR-T Cells)

Colorectal Neoplasia · Colorectal Neoplasia

#ColorectalNeoplasia#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 10상태 RECRUITING
CGTBiologicstaleChongqing University Cancer Hos…Phase 2

Oncolytic Virus H101 (Oncolytic Virus H101)

Rectal Neoplasms; Rectal Adenocarcinoma · Rectal Neoplasms

#RectalNeoplasms#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 10상태 RECRUITING
CGTBiologicstaleNovartisPhase 1

huCART19 (huCART19)

Acute Lymphocytic Leukemia; Diffuse Large Cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 10상태 ACTIVE
CGTBiologicstaleImmunityBio, Inc.Phase 1

super NK cell (super NK cell)

AML, Adult; Minimal Residual Disease · AML, Adult

#AMLAdult#CGT#Phase1#세포유전치료#CAR-T+5
효능 ORR 0%임상시험 10상태 ACTIVE
CGTBiologicMiltenyi Biomedicine GmbHPhase 2

MB-CART2019.1 (zamtocabtagene autoleucel, zamtocabtagene autoleucel (MB-CART2019.1))

Refractory Diffuse Large B Cell Lymphoma (DLBCL); Relapsed Diffuse Large B Cell Lymphoma · B-Cell Neoplasm

#B-CellNeoplasm#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 10상태 RECRUITING
CGTBiologicstaleNanjing IASO Biotechnology Co.,…Phase 2

Eque-cel (Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection, Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (Eque-cel))

Relapsed/Refractory Multiple Myeloma · BCMA

#BCMA#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 9상태 RECRUITING

10 / 62 페이지

← 이전다음 →